Navigation Links
The AACR to host second cancer research conference in Jordan
Date:3/5/2010

PHILADELPHIA The second American Association for Cancer Research Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic provides attendees with an overview of the most advanced cancer research in a variety of fields, including the tumor microenvironment, microRNAs, signal transduction and novel therapeutic development. The conference takes place March 7-10, 2010, at the King Hussein Bin Talal Convention Center, Dead Sea, Jordan.

Held under the patronage of His Majesty King Abdullah II Ibn Al Hussein, this conference is the only large cancer meeting in the Middle East; it attracts researchers from more than 27 countries.

This conference on advancements in cancer research is one way the AACR is forging international collaborations and creating a venue for an interdisciplinary exchange of information, which is essential for progress in the fight against cancer.

"This AACR conference provides the opportunity for researchers to create a dialogue they may not otherwise have. It also provides access to data on regional differences in cancer instances, diet and genetics. This information can be very revealing in the study of cancer and its global variations," said conference co-chairperson Tom Curran, Ph.D., deputy scientific director of The Children's Hospital of Philadelphia Research Institute.

Curran noted that the global nature of this conference will raise new issues in personalized medicine, which has long been a focus of Western medicine, but could have unique implications for the Middle Eastern region of the world.

"The Advances in Cancer Research conference is a step in the right direction for the globalization of science," said conference chairperson Samir N. Khleif, M.D., head of the cancer vaccine section at the National Cancer Institute. "There is opportunity, talent and potential all over the world that needs to be nurtured and grown."

Khleif said the selection of the venue for this conference was particularly important.

"We need to reach out to scientists in developing countries and emerging economies in effort to provide them with an opportunity to interact with high-level scientists globally," said Khleif. "The opportunities that this conference provides to start these collaborations are vital."


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. 60 second test could help early diagnosis of common brain diseases
2. BIO-key Reports Second Quarter 2007 Results
3. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
4. Weight gain between first and second pregnancies associated with increased odds of male second child
5. Decisions on the second round of the Excellence Initiative announced
6. Second genetic link to weight and obesity
7. A new analysis method allows to find out the sex of the baby from the second month of pregnancy
8. Second Life a first for UH department of health and human performance
9. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
10. L-1 Identity Solutions to Hold Supplemental Second Quarter 2008 Financial Results Q&A Conference Call at 2:00p.m. (ET) Today
11. TORC at UH turns to virtual world of Second Life for new study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... , ... October 11, 2017 , ... ... President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and ... Labs ), Inc. has been selected for membership in ARCS Alumni Hall ...
(Date:10/11/2017)... , ... October 11, 2017 , ... Personal eye wash is a basic first aid ... at a time. So which eye do you rinse first if a dangerous substance enters ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its dirt ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... it will be hosting a Webinar titled, “Pathology is going digital. Is your ... on digital pathology adoption best practices and how Proscia improves lab economics and ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
Breaking Biology Technology: